Search Results 291-300 of 19026 for creatine

1. PET Scan Imaging in Assessing Response in Patients with Esophageal Cancer Receiving Combination Chemotherapy - Mayo Clinic

   Creatinine clearance ≥ 60 mL/min; AST/ALT ≤ 2.5 times ULN; Not pregnant or nursing; Negative pregnancy test; No prior malignancy within 5 years, with the ...

2. A Study of Allopurinol to Relieve Symptoms in Patients with Heart Failure and High Uric Acid Levels - Mayo Clinic

   Serum creatinine > 3 mg/dL or estimated GFR < 20 ml/min; Evidence of active hepatitis with ALT and AST greater than 3x normal; Any condition other than HF ...

3. A Study of Donor Stem Cell Transplant in Treating Young Patients With Acute Myeloid Leukemia, or Refractory or Relapsed Acute Myelogenous Leukemia - Mayo Clinic

   Creatinine clearance or radioisotope glomerular filtration rate at least 60 mL/min OR creatinine adjusted according to age; HIV negative; Not pregnant or ...

4. Durvalumab and Tremelimumab With or Without High or Low-Dose Radiation Therapy in Treating Patients With Metastatic Colorectal or Non-small Cell Lung Cancer - Mayo Clinic

   Creatinine within normal institutional limits OR; Creatinine clearance ≥ 60 mL/min/1.73 m^2 for patients with creatinine levels above institutional normal ...

5. Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies - Mayo Clinic

   Serum creatinine ≤.5 x ULN or creatinine clearance ≥0 mL/min based on either urine collection or Cockcroft Gault estimation;; Prothrombin time (PT) ...

6. A Study to Evaluate Ribociclib Plus Letrozole to Treat Cancer of the Ovary, Fallopian Tube or Peritoneum - Mayo Clinic

   Serum creatinine < 1.5 mg/dL or creatinine clearance ≥ 50 mL/min;; In the absence of liver metastases, alanine aminotransferase (ALT) and aspartate ...

7. Daily Oral Regorafenib for Chemotherapy-Refractory, Metastatic and Locally Advanced Angiosarcoma - Mayo Clinic

   Serum creatinine =< 1.5 x the ULN. International normalized ratio (INR)/partial thromboplastin time (PTT) < 1.5 x ULN. Platelet count > 100000/mm^3 ...

8. A Study to Evaluate AMG 701 in Subjects with Multiple Myeloma - Mayo Clinic

   calculated or measured creatinine clearance ≥ 30 mL/min using: the Cockcroft-Gault equation; OR; via 24-hour urine collection with plasma and urine ...

9. Study of Single Agent CJM112, and PDR001 in Combination With LCL161 or CJM112 in Patients With Multiple Myeloma - Mayo Clinic

   Calculated creatinine clearance < 30 ml/min according to Cockcroft-Gault equation Other exclusion criteria included in the protocol might apply.

10. A Study of the Safety and Effectiveness of TH-302 Combined with Gemcitabine and Compared with Gemcitabine Alone for Previously Untreated Patients with Pancreatic Adenocarcinoma - Mayo Clinic

    If liver metastases are present, then less than or equal to 5 times ULN is allowed. Acceptable renal function. Serum creatinine less than or equal to ULN.